Print Page
4009:
Are Mast Cells and Eosinophils the Preferred Targets for Anti-Allergic Therapy?
Mast Cell/Eosinophilic Disorders
Monday, March 5, 2018: 7:00 AM-8:00 AM
Hyatt, Convention Level, Celebration 9
1.00 CME/CE
Seminar
Primary Discussion Leaders:
Francesca Levi-Schaffer, PhD, PharmD, FAAAAI
Lisa A. Spencer, PhD FAAAAI

Learning Objectives:
  1. Discuss new molecules as targets for therapy on mast cells and eosinophils
Handouts
  • Levi-Schaffer_Spencer_2018.pdf (905.8 kB)
    • See more of: Session
    << Previous Session | Next Session >>